Liver / Pancreas Archives - Insights Get the latest news and education from Mayo Clinic Laboratories Tue, 02 Sep 2025 13:47:44 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 Genetic Testing for Pancreatitis https://news.mayocliniclabs.com/2025/09/03/genetic-testing-for-pancreatitis/ https://news.mayocliniclabs.com/2025/09/03/genetic-testing-for-pancreatitis/#respond Wed, 03 Sep 2025 10:00:00 +0000 https://news.mayocliniclabs.com/?p=118100 Genetic Testing for PancreatitisRegister now – Nov. 12, 2025 - PACE/State of FL - Review known genetic predisposing factors to acute or chronic pancreatitis, as well as define who may benefit from genetic testing.

The post Genetic Testing for Pancreatitis appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2025/09/03/genetic-testing-for-pancreatitis/feed/ 0
Expanded Pancreatitis Gene Panel (PANGP) https://news.mayocliniclabs.com/2025/07/08/expanded-pancreatitis-gene-panel-pangp/ https://news.mayocliniclabs.com/2025/07/08/expanded-pancreatitis-gene-panel-pangp/#respond Tue, 08 Jul 2025 12:00:00 +0000 https://news.mayocliniclabs.com/?p=117205 Expanded Pancreatitis Gene Panel (PANGP)Clinically relevant overview of key genetic factors, testing strategies, and post-result care.

The post Expanded Pancreatitis Gene Panel (PANGP) appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2025/07/08/expanded-pancreatitis-gene-panel-pangp/feed/ 0
Targeted panel boosts accuracy of hereditary pancreatitis testing: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C. https://news.mayocliniclabs.com/2024/03/26/targeted-panel-boosts-accuracy-of-hereditary-pancreatitis-testing-linda-hasadsri-m-d-ph-d-and-huong-t-cabral-m-s-cgs/ https://news.mayocliniclabs.com/2024/03/26/targeted-panel-boosts-accuracy-of-hereditary-pancreatitis-testing-linda-hasadsri-m-d-ph-d-and-huong-t-cabral-m-s-cgs/#respond Tue, 26 Mar 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=109715 Targeted panel boosts accuracy of hereditary pancreatitis testing: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families.

The post Targeted panel boosts accuracy of hereditary pancreatitis testing: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C. appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2024/03/26/targeted-panel-boosts-accuracy-of-hereditary-pancreatitis-testing-linda-hasadsri-m-d-ph-d-and-huong-t-cabral-m-s-cgs/feed/ 0
Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D. https://news.mayocliniclabs.com/2024/02/13/tests-aid-diagnosis-of-primary-biliary-cholangitis-anne-tebo-ph-d/ https://news.mayocliniclabs.com/2024/02/13/tests-aid-diagnosis-of-primary-biliary-cholangitis-anne-tebo-ph-d/#respond Tue, 13 Feb 2024 14:00:00 +0000 https://news.mayocliniclabs.com/?p=108782 Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune liver disease.

The post Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D. appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2024/02/13/tests-aid-diagnosis-of-primary-biliary-cholangitis-anne-tebo-ph-d/feed/ 0
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. https://news.mayocliniclabs.com/2023/12/26/assay-finds-genetic-cause-of-low-bile-flow-devin-oglesbee-ph-d/ https://news.mayocliniclabs.com/2023/12/26/assay-finds-genetic-cause-of-low-bile-flow-devin-oglesbee-ph-d/#respond Tue, 26 Dec 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=107067 Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

The post Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2023/12/26/assay-finds-genetic-cause-of-low-bile-flow-devin-oglesbee-ph-d/feed/ 0
Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D. https://news.mayocliniclabs.com/2023/06/20/updated-assay-guides-diagnosis-of-autoimmune-liver-disease-anne-tebo-ph-d/ https://news.mayocliniclabs.com/2023/06/20/updated-assay-guides-diagnosis-of-autoimmune-liver-disease-anne-tebo-ph-d/#respond Tue, 20 Jun 2023 13:00:00 +0000 https://news.mayocliniclabs.com/?p=101281 Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D.Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology.

The post Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D. appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2023/06/20/updated-assay-guides-diagnosis-of-autoimmune-liver-disease-anne-tebo-ph-d/feed/ 0
Direct Ethanol Biomarker Testing: PETH https://news.mayocliniclabs.com/2022/09/13/direct-ethanol-biomarker-testing-peth-test-in-focus/ https://news.mayocliniclabs.com/2022/09/13/direct-ethanol-biomarker-testing-peth-test-in-focus/#respond Tue, 13 Sep 2022 13:00:00 +0000 https://news.mayocliniclabs.com/?p=87079 Direct Ethanol Biomarker Testing: PETHPaul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for alcohol use.

The post Direct Ethanol Biomarker Testing: PETH appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2022/09/13/direct-ethanol-biomarker-testing-peth-test-in-focus/feed/ 0
Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus] https://news.mayocliniclabs.com/2019/05/08/hepatitis-c-virus-genotypic-antiviral-drug-resistance-a-test-in-focus/ https://news.mayocliniclabs.com/2019/05/08/hepatitis-c-virus-genotypic-antiviral-drug-resistance-a-test-in-focus/#respond Wed, 08 May 2019 15:00:27 +0000 https://news.mayocliniclabs.com/?p=51164 Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus]Joseph Yao, M.D., gives an overview of this new test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be taken due to the results of this testing.

The post Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus] appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2019/05/08/hepatitis-c-virus-genotypic-antiviral-drug-resistance-a-test-in-focus/feed/ 0
Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] https://news.mayocliniclabs.com/2019/03/18/nonalcoholic-steatohepatitis-nash-fibrotest-a-test-in-focus/ https://news.mayocliniclabs.com/2019/03/18/nonalcoholic-steatohepatitis-nash-fibrotest-a-test-in-focus/#respond Mon, 18 Mar 2019 23:10:05 +0000 https://news.mayocliniclabs.com/?p=49753 Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus]Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.

The post Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] appeared first on Insights.

]]>
https://news.mayocliniclabs.com/2019/03/18/nonalcoholic-steatohepatitis-nash-fibrotest-a-test-in-focus/feed/ 0